Porton Advanced Solutions announced that it has raised over $80 million in a round of funding led by new investor China Merchants Health Care Holdings Company Limited on August 19, 2022. The transaction included participation from new investors Shenzhen China Merchants Capital Partnership Enterprise (L.P.), a fund managed by China Merchants Capital Investment Co., Ltd., China Merchants Securities Investment Co., Ltd., Fosun Health Capital, a fund managed by Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Investment Arm, Gortune Investment Co., Ltd., SDIC Taikang Trust Co., Ltd., returning investors Porton Pharma Solutions Ltd., Shanghai CS Capital Co., Ltd, Guangzhou Ruilian Investment Partnership Enterprise (Limited Partnership), Beijing Momentum Investment Management Co., Ltd., and Huimei Capital.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 CNY | +2.10% | +5.14% | -32.49% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.49% | 1.28B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Porton Advanced Solutions announced that it has received $80 million in funding from a group of investors